Cargando…
Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients
OBJECTIVES: In addition to motor symptoms, bladder dysfunction is a major clinical issue in patients with Parkinson disease (PD). Istradefylline is adenosine A2A receptor antagonist approved for PD patients with wearing-off symptoms. The aim of this study was to determine the long-term effects of is...
Autores principales: | Kitta, Takeya, Yabe, Ichiro, Kanno, Yukiko, Higuchi, Madoka, Ouchi, Mifuka, Togo, Mio, Moriya, Kimihiko, Takahashi, Ikuko, Matsushima, Masaaki, Sasaki, Hidenao, Shinohara, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965927/ https://www.ncbi.nlm.nih.gov/pubmed/29672326 http://dx.doi.org/10.1097/WNF.0000000000000281 |
Ejemplares similares
-
Reliability of manometry for assessing pelvic floor muscle function in healthy men
por: Ouchi, Mifuka, et al.
Publicado: (2020) -
Episodes of Febrile Urinary Tract Infections Occur More Often in the Winter in Patients with Spina Bifida
por: Kitta, Takeya, et al.
Publicado: (2023) -
Mechanisms of D1/D2-like dopaminergic agonist, rotigotine, on lower urinary tract function in rat model of Parkinson’s disease
por: Ouchi, Mifuka, et al.
Publicado: (2022) -
Bladder outlet obstruction disrupts circadian bladder function in mice
por: Kitta, Takeya, et al.
Publicado: (2020) -
Animal Model for Lower Urinary Tract Dysfunction in Parkinson’s Disease
por: Kitta, Takeya, et al.
Publicado: (2020)